Cavernous Malformations: Popcorn on SWI, Real Hemorrhage Numbers, and When to Operate
An incidental cavernoma and a brainstem cavernoma that has bled are separated by nearly a factor of ten in five-year risk. The popcorn lesion is common; the operation is for the few that earn it.
Presentation and location price the cavernoma — incidental cortical and once-bled brainstem are different diseases.
- →A cavernous malformation is a low-flow mulberry of dilated capillary caverns — angiographically occult, diagnosed on MRI by the "popcorn" core with a hemosiderin rim, best seen on susceptibility sequences.
- →The pooled individual-patient data put 5-year hemorrhage risk at roughly 4% for an incidental non-brainstem lesion — and around 30% for a brainstem cavernoma that has already bled. Everything in management follows that spread.
- →Multiple cavernomas suggest the familial syndromes (CCM1/KRIT1 and relatives — autosomal dominant, new lesions over time), which changes counseling and imaging, not the per-lesion math.
- →Most cavernomas are observed. Surgery is for the lesion that keeps declaring itself: recurrent symptomatic hemorrhage in accessible locations, or medically refractory cavernoma-related epilepsy.
- →Two myth-corrections: the associated venous anomaly (DVA) is left alone, and indicated antithrombotics are not automatically forbidden — observational data have not shown them to increase cavernoma hemorrhage.
Cavernomas enter the chart in three costumes. The incidental one, found on an MRI for headaches, that mostly needs to be explained rather than treated. The seizure one — a first convulsion, a rim of old blood in the temporal lobe. And the frightening one: a young patient with a pontine bleed, double vision, and a lesion the size of a fingertip sitting where nothing spare exists. One name, three very different conversations — priced apart by two variables: has it bled, and where does it live?2
What it is, and how MRI makes the diagnosis
A cerebral cavernous malformation (cavernoma, CCM) is a cluster of dilated, thin-walled vascular caverns with no intervening brain — a low-flow lesion that leaks and thromboses in small cycles rather than shunting like the high-flow tangle in the AVM chapter. Because flow is slow, catheter angiography is typically normal — this is the classic "angiographically occult" lesion — and the diagnosis is an MRI one: a reticulated popcorn core of blood products in varied ages, ringed by hemosiderin, with susceptibility sequences (the same SWI that finds microbleeds) lighting up lesions T2 misses.1 A neighboring developmental venous anomaly is common; it is the region's normal venous drainage wearing an unusual costume, and it is not resected.
One lesion or many? Solitary cavernomas (often DVA-associated) are usually sporadic. Multiple lesions — or a cavernoma with the right family story — point to the autosomal-dominant familial syndromes (KRIT1/CCM1, CCM2, PDCD10/CCM3), in which new lesions form over a lifetime; that changes genetic counseling and the imaging cadence, and it is a young-patient context worth flagging in the same breath as the rest of the young-stroke zebra list.1
The numbers that decide everything
The individual-patient meta-analysis of untreated cavernomas is the anchor: over five years, hemorrhage risk ran from roughly 4% for a non-brainstem cavernoma that had never bled, through intermediate figures for brainstem-unbled and hemispheric-bled lesions, to approximately 30% for a brainstem cavernoma presenting with hemorrhage — with rebleeding risk highest early and declining after the first years.2 Two clinical translations. First, the incidental cortical popcorn deserves a calm visit: its yearly number is small. Second, the once-bled brainstem lesion deserves a neurosurgical conversation at a center that sees these — not because surgery is automatic, but because the natural history is no longer benign.
"Cavernoma" without a location and a bleeding history is a word, not a prognosis.
Cavernoma bleeds are usually smaller and less devastating than arterial hemorrhages — brainstem excepted, where millimeters are eloquent — and the deficits often accumulate stepwise with each event, which is exactly why recurrent hemorrhage drives the surgical calculus.
Management, by scenario
- Incidental lesion: education, a baseline susceptibility MRI, and follow-up imaging for change or symptoms — guidelines endorse conservative management as the default.1 No activity prohibition list accompanies it.
- Seizure presentation: treat as lesional epilepsy — an antiseizure medication after a first seizure is generally warranted (drug-choice logic shared with the post-stroke epilepsy chapter). For epilepsy that proves medically refractory and maps to the cavernoma, resection has excellent seizure-freedom rates and is one of the two classic surgical indications.1
- Symptomatic hemorrhage: acute care per hemorrhage pathway, then a risk conversation anchored to the numbers above. Surgery is favored for accessible lesions with recurrent symptomatic hemorrhage; brainstem lesions demand the most experienced hands and usually more than one event before resection wins the ledger. Radiosurgery is the contested consolation option for surgically inaccessible, repeatedly hemorrhaging lesions.
- Familial disease: genetic counseling, screening discussion for relatives, and susceptibility MRI surveillance — with the honesty that we follow lesions, not treat the genome, at present.
- Antithrombotics: the reflex "no blood thinners with a cavernoma" is not supported — observational cohorts and the pooled analyses have associated antithrombotic use with, if anything, no increase in hemorrhage. An indicated antiplatelet or anticoagulant (framework: antithrombotic selection) is generally not vetoed by an incidental cavernoma — individualized, as ever, for the once-bled brainstem lesion.1
The bottom line
Read the popcorn on SWI, then ask the two pricing questions: bled before, and where. The incidental hemispheric cavernoma gets a number small enough to live comfortably beside, a baseline scan, and no prohibitions. The seizure lesion gets epilepsy care, with resection held for refractory cases. The hemorrhagic brainstem lesion gets a real surgical conversation at an experienced center, timed by recurrence rather than reflex. Leave the DVA alone, don't reflexively strip indicated antithrombotics, and flag the multi-lesion patient for the familial workup. Common lesion, uncommon operations — in that order.
Frequently asked questions.
What is a cavernous malformation?
A low-flow cluster of dilated, thin-walled vascular caverns ("mulberry" or "popcorn" lesion) in the brain or brainstem. It leaks and re-thromboses in small cycles, is invisible on catheter angiography, and is diagnosed on MRI — a mixed-age blood-product core with a hemosiderin rim, best seen with susceptibility sequences.
What is the bleeding risk of a cavernoma?
It depends on history and location. In pooled patient-level data, five-year hemorrhage risk was roughly 4% for an incidental non-brainstem cavernoma and around 30% for a brainstem cavernoma that had already bled, with intermediate figures between — and rebleeding risk front-loaded in the first couple of years after an event.
Does a cavernoma need surgery?
Usually not. Surgery is considered for two situations: recurrent symptomatic hemorrhage from an accessible lesion (brainstem lesions only at experienced centers, typically after repeated events), and medically refractory epilepsy attributable to the cavernoma, where resection has high seizure-freedom rates. Incidental lesions are observed.
What does it mean to have multiple cavernomas?
Multiple lesions suggest the familial cavernous malformation syndromes (mutations in KRIT1/CCM1, CCM2, or PDCD10/CCM3), inherited in an autosomal dominant pattern, in which new lesions can form over a lifetime. That prompts genetic counseling, a screening conversation for relatives, and periodic susceptibility MRI.
Can a patient with a cavernoma take blood thinners?
Often yes. Observational data have not shown indicated antiplatelets or anticoagulants to increase cavernoma hemorrhage — some analyses suggest the opposite association — so an incidental cavernoma generally does not veto a needed antithrombotic. Decisions are individualized for high-risk lesions such as a brainstem cavernoma with prior hemorrhage.
What is the venous anomaly next to my cavernoma?
A developmental venous anomaly (DVA) — an unusual-looking but functional venous drainage pattern that frequently accompanies sporadic cavernomas. It drains normal brain and is deliberately left alone during any treatment; removing it risks venous infarction.
References.
- Akers A, Al-Shahi Salman R, Awad IA, et al. Synopsis of Guidelines for the Clinical Management of Cerebral Cavernous Malformations: Consensus Recommendations Based on Systematic Literature Review by the Angioma Alliance Scientific Advisory Board Clinical Experts Panel. Neurosurgery. 2017;80(5):665-680. PubMed
- Horne MA, Flemming KD, Su IC, et al. Clinical course of untreated cerebral cavernous malformations: a meta-analysis of individual patient data. Lancet Neurol. 2016;15(2):166-173. PubMed
Related guides
Keep building the picture.
- Cerebral microbleeds & anticoagulation The SWI sequence that finds both, and the mimic distinction.
- Brain AVMs The high-flow tangle this low-flow lesion is not.
- Post-stroke epilepsy Lesional epilepsy care when the cavernoma declares itself with a seizure.
- Antithrombotic selection Indicated therapy is not automatically vetoed by the popcorn lesion.
Article written by